This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schaaf, H. S.
Right arrow Articles by Donald, P. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schaaf, H. S.
Right arrow Articles by Donald, P. R.
Related Collections
Right arrow Infectious Disease & Immunity
Right arrowRelated AAP Red Book topics:
Tuberculosis
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 109 No. 5 May 2002, pp. 765-771

Evaluation of Young Children in Contact With Adult Multidrug-Resistant Pulmonary Tuberculosis: A 30-Month Follow-up

H. Simon Schaaf, MMed (Paed), Robert P. Gie, MMed (Paed), Magdalene Kennedy, Dipl Nurs, Nulda Beyers, PhD, Peter B. Hesseling, MD and Peter R. Donald, MD

From the Department of Paediatrics and Child Health, Faculty of Health Sciences, University of Stellenbosch and Tygerberg Children’s Hospital, Western Cape Province, South Africa

--> Setting. The Western Cape Province of South Africa, an area with a high tuberculosis (TB) incidence, where initial multidrug resistance (MDR) among adult TB cases was 1.1% during 1992–1993.

Objective. To determine the long-term prevalence of TB infection and disease in children in household contact with adults with MDR pulmonary TB, and to establish the efficacy of chemoprophylaxis in preventing disease in these children.

Method. Children <5 years old in contact with 73 MDR TB adults were evaluated. Disease was treated by prescribing at least 2 drugs to which the adult’s strain was susceptible. The remaining children were classified as infected or noninfected and received chemoprophylaxis according to the index’s strain susceptibility or were followed up and treated when indicated. All were followed up for 30 months.

Results. At the initial evaluation 125 children were seen, median age 27.5 months. Of these, 119 were followed up. Fourteen (12%) had disease, 61 (51%) were infected only, and 44 (37%) were noninfected. By 30-month follow-up, 29 (24%) had developed disease and 64 (54%) were infected only. Four adult-child pair Mycobacterium tuberculosis isolates were compared by DNA fingerprinting; 3 were identical. All children who developed TB disease were clinically cured. Two (5%) of 41 children who received appropriate chemoprophylaxis and 13 (20%) of 64 who did not, developed TB during follow-up (odds ratio: 4.97).

Conclusion. The study confirms MDR TB transmission to childhood contacts. Seventy-eight percent of children were infected or developed disease. Appropriate chemoprophylaxis may prevent disease in these children.

Key Words: tuberculosis • multidrug-resistant • children • contacts • follow-up • chemoprophylaxis

Abbreviations: TB, tuberculosis • MDR, multidrug-resistant • CI, confidence interval • HIV, human immunodeficiency virus • ESR, erythrocyte sedimentation rate • RFLP, restriction fragment length polymorphism


Received for publication Jul 26, 2001; Accepted Dec 20, 2001.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
AJPHHome page
H. S. Schaaf, B. J. Marais, A. C. Hesseling, W. Brittle, and P. R. Donald
Surveillance of Antituberculosis Drug Resistance Among Children From the Western Cape Province of South Africa--An Upward Trend
Am J Public Health, August 1, 2009; 99(8): 1486 - 1490.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
L. Richeldi, K. Ewer, M. Losi, B. M. Bergamini, K. Millington, L. M. Fabbri, and A. Lalvani
T-Cell-Based Diagnosis of Neonatal Multidrug-Resistant Latent Tuberculosis Infection
Pediatrics, January 1, 2007; 119(1): e1 - e5.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
P. C. Drobac, J. S. Mukherjee, J. K. Joseph, C. Mitnick, J. J. Furin, H. del Castillo, S. S. Shin, and M. C. Becerra
Community-based therapy for children with multidrug-resistant tuberculosis.
Pediatrics, June 1, 2006; 117(6): 2022 - 2029.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
Pediatric Tuberculosis Collaborative Group
Targeted Tuberculin Skin Testing and Treatment of Latent Tuberculosis Infection in Children and Adolescents
Pediatrics, October 1, 2004; 114(4/S2): 1175 - 1201.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child.Home page
H S Schaaf, K Shean, and P R Donald
Culture confirmed multidrug resistant tuberculosis: diagnostic delay, clinical features, and outcome
Arch. Dis. Child., December 1, 2003; 88(12): 1106 - 1111.
[Abstract] [Full Text] [PDF]